FF
Schedule 13D filing
Fairmount Funds Management LLC disclosed a 20% stake in Korsana Biosciences, Inc. (CYCN)
Fairmount Funds Management LLC reported owning 20% of Korsana Biosciences, Inc. (CYCN) (9,106,420 shares) in a Schedule 13D filed Sep 11, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 11, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.